![Chris Chapman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Chapman
Corporate Officer/Principal at Dermavant Sciences Ltd.
Chris Chapman active positions
Companies | Position | Start | End |
---|---|---|---|
Dermavant Sciences Ltd.
![]() Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 2020-01-21 | - |
Career history of Chris Chapman
Training of Chris Chapman
Towson University | Undergraduate Degree |
Statistics
International
United Kingdom | 2 |
United States | 2 |
Operational
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Dermavant Sciences Ltd.
![]() Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Chris Chapman
- Experience